Skip to content

Clinical trials

Observational Breast Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Diseases Phase: Observational Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20071
20102
20111
20162
20191
20212
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sysmex America, Inc.3
State University of New York - Upstate Medical University2
Abramson Cancer Center at Penn Medicine1
Concure Oncology-Breast Microseed Inc.1
Endeavor Health1
Memorial Sloan Kettering Cancer Center1
MetriTrack, Inc.1
Myriad Genetic Laboratories, Inc.1
National Cancer Institute (NCI)1
iSono Health, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Diseases13
Breast Neoplasms9
Neoplasm Metastasis3
Neoplasms3
Neoplasms by Site3
Skin Diseases2
Carcinoma, Intraductal, Noninfiltrating1
Cystic Fibrosis1
Fibroadenoma1
Mastodynia1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.